Ra Medical Systems, Inc. (RMED)
NYSEAMERICAN: RMED · IEX Real-Time Price · USD
0.301
0.018 (6.47%)
At close: May 20, 2022 4:00 PM
0.292
-0.009 (-3.087%)
After-hours:May 20, 2022 7:48 PM EDT
Balance Sheet (Quarterly)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ended | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2016-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 17.65 | 15.05 | 20.62 | 20.22 | 15.95 | 23.91 | 33.65 | 29.38 | 18.44 | 14.58 | 14.51 | 11.79 | 55.13 | 64.32 | 4.92 | 9.77 | - | 8.24 | - | 3.92 |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 15.99 | 25.96 | 36.6 | 0 | 0 | 0 | 0 | - | 0 | - | 0 |
Cash & Cash Equivalents | 17.65 | 15.05 | 20.62 | 20.22 | 15.95 | 23.91 | 33.65 | 29.38 | 23.44 | 30.58 | 40.48 | 48.39 | 55.13 | 64.32 | 4.92 | 9.77 | 0 | 8.24 | 0 | 3.92 |
Cash Growth | 10.64% | -37.07% | -38.73% | -31.18% | -31.94% | -21.82% | -16.87% | -39.28% | -57.48% | -52.46% | 723.52% | 395.32% | - | 680.81% | - | 149.15% | - | - | - | - |
Receivables | 0.03 | 0.02 | 0.02 | 0.23 | 0.16 | 0.02 | 0.48 | 0.47 | 0.68 | 0.79 | 1.3 | 1.45 | 1.29 | 1.32 | 1.35 | 0.76 | - | 0.52 | - | 0.39 |
Inventory | 1.06 | 0.99 | 1 | 2.32 | 2.25 | 0.88 | 2.59 | 2.7 | 2.77 | 2.78 | 2.57 | 2.34 | 2.22 | 2.1 | 1.28 | 1.26 | - | 1.2 | - | 0.87 |
Other Current Assets | 1.28 | 1.04 | 1.17 | 1.31 | 1.56 | 2.81 | 0.47 | 1.22 | 1.79 | 1.86 | 1.11 | 1.3 | 1.82 | 1.5 | 0.24 | 0.27 | - | 0.09 | - | 0.12 |
Total Current Assets | 20.01 | 17.09 | 22.8 | 24.08 | 19.92 | 27.62 | 37.18 | 33.78 | 28.69 | 36 | 45.45 | 53.49 | 60.45 | 69.23 | 7.78 | 12.06 | - | 10.04 | - | 5.31 |
Property, Plant & Equipment | 3.7 | 3.92 | 4.24 | 4.96 | 5.21 | 5.01 | 6.16 | 6.77 | 7.44 | 7.89 | 8.34 | 8.77 | 8.61 | 4.76 | 2.81 | 2.26 | - | 1.16 | - | 0.51 |
Other Long-Term Assets | 0.04 | 0.04 | 0.05 | 0.12 | 0.13 | 0.81 | 0.12 | 0.14 | 0.18 | 0.2 | 0.21 | 0.22 | 0.21 | 0.05 | 3.6 | 2.29 | - | 0.07 | - | 0.03 |
Total Long-Term Assets | 3.73 | 3.96 | 4.28 | 5.08 | 5.34 | 5.82 | 6.28 | 6.91 | 7.61 | 8.08 | 8.55 | 8.99 | 8.83 | 4.8 | 6.41 | 4.55 | - | 1.23 | - | 0.53 |
Total Assets | 23.75 | 21.04 | 27.08 | 29.16 | 25.26 | 33.44 | 43.45 | 40.69 | 36.3 | 44.08 | 54 | 62.47 | 69.28 | 74.04 | 14.19 | 16.61 | - | 11.27 | - | 5.84 |
Accounts Payable | 1.17 | 0.99 | 0.54 | 1.08 | 0.98 | 0.47 | 0.9 | 1.87 | 1.36 | 1.53 | 1 | 1.52 | 1.41 | 1.13 | 3.34 | 2.44 | - | 0.43 | - | 0.47 |
Deferred Revenue | 0 | 0 | 0 | 2.35 | 2.39 | 0 | 2.39 | 2.71 | 3.05 | 3.26 | 3.08 | 3.03 | 2.9 | 2.49 | 2.52 | 2.51 | - | 2.49 | - | 2.58 |
Current Debt | 0.29 | 0.28 | 0.3 | 0.32 | 1.01 | 1.04 | 0.82 | 0.64 | 0.62 | 0.61 | 0.68 | 0.67 | 0.66 | 0.29 | 0.03 | 0.04 | - | 0.04 | - | 0.04 |
Other Current Liabilities | 2.27 | 4.12 | 2.63 | 1.46 | 1.6 | 6.25 | 3.94 | 3.09 | 1 | 1.41 | 3.23 | 1.08 | 0.12 | 2.04 | 0.94 | 0.97 | - | -0.33 | - | -0.39 |
Total Current Liabilities | 3.74 | 5.39 | 3.48 | 5.21 | 5.98 | 7.76 | 8.04 | 8.3 | 6.02 | 6.81 | 7.98 | 6.3 | 5.09 | 5.95 | 6.83 | 5.95 | - | 2.63 | - | 2.71 |
Long-Term Debt | 1.9 | 1.98 | 2.05 | 2.13 | 3.52 | 3.84 | 4.22 | 4.56 | 2.72 | 2.89 | 3.12 | 3.29 | 3.46 | 0.56 | 0 | 0 | - | 0.02 | - | 0.07 |
Other Long-Term Liabilities | 0 | 0 | 0 | 0.57 | 0.62 | 0.69 | 0.66 | 0.85 | 1.08 | 1.23 | 1.16 | 0.99 | 0.94 | 0.82 | 0.88 | 0.88 | - | 16.23 | - | 3.45 |
Total Long-Term Liabilities | 1.9 | 1.98 | 2.05 | 2.69 | 4.14 | 4.53 | 4.88 | 5.4 | 3.8 | 4.12 | 4.28 | 4.28 | 4.4 | 1.38 | 0.88 | 0.88 | - | 16.25 | - | 3.51 |
Total Liabilities | 5.64 | 7.37 | 5.53 | 7.9 | 10.12 | 12.29 | 12.92 | 13.71 | 9.83 | 10.93 | 12.26 | 10.58 | 9.48 | 7.33 | 7.71 | 6.83 | - | 18.88 | - | 6.22 |
Total Debt | 2.2 | 2.26 | 2.36 | 2.45 | 4.53 | 4.89 | 5.04 | 5.2 | 3.34 | 3.5 | 3.79 | 3.96 | 4.11 | 0.85 | 0.03 | 0.04 | - | 0.06 | - | 0.11 |
Debt Growth | -51.58% | -53.65% | -53.28% | -52.94% | 35.64% | 39.73% | 32.90% | 31.22% | -18.77% | 311.29% | 12543.33% | 9326.19% | - | 1249.21% | - | -60.75% | - | - | - | - |
Common Stock | 201.88 | 191.95 | 191.53 | 186.95 | 175.58 | 174.35 | 173.3 | 161.96 | 151.33 | 150.28 | 149.12 | 141.84 | 134.67 | 126.93 | 51.77 | 50.26 | 0 | 21.77 | 0 | 11.24 |
Retained Earnings | -183.77 | -178.27 | -169.99 | -165.69 | -160.44 | -153.2 | -142.76 | -134.98 | -124.86 | -117.16 | -107.41 | -90 | -74.87 | -60.22 | -45.28 | -40.48 | - | -29.39 | - | -11.62 |
Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.04 | 0.05 | 0 | 0 | 0 | 0 | - | 0 | - | 0 |
Shareholders' Equity | 18.11 | 13.67 | 21.55 | 21.26 | 15.15 | 21.15 | 30.54 | 26.98 | 26.47 | 33.15 | 41.74 | 51.9 | 59.8 | 66.71 | 6.48 | 9.78 | - | -7.62 | - | -0.38 |
Total Liabilities and Equity | 23.75 | 21.04 | 27.08 | 29.16 | 25.26 | 33.44 | 43.45 | 40.69 | 36.3 | 44.08 | 54 | 62.47 | 69.28 | 74.04 | 14.19 | 16.61 | 0 | 11.27 | 0 | 5.84 |
Net Cash / Debt | 15.46 | 12.78 | 18.26 | 17.78 | 11.42 | 19.02 | 28.61 | 24.19 | 20.1 | 27.08 | 36.68 | 44.43 | 51.02 | 63.47 | 4.89 | 9.73 | 0 | 8.17 | 0 | 3.81 |
Net Cash / Debt Growth | 35.34% | -32.81% | -36.16% | -26.50% | -43.17% | -29.76% | -22.02% | -45.56% | -60.60% | -57.33% | 650.93% | 356.76% | - | 676.43% | - | 155.03% | - | - | - | - |
Net Cash Per Share | 0.77 | 2.53 | 2.85 | 4.35 | 3.92 | 11.20 | 11.99 | 25.59 | 36.48 | 50.04 | 68.59 | 85.44 | 100.48 | 171.90 | 14.89 | 29.97 | - | 26.29 | - | 13.72 |
Working Capital | 16.28 | 11.7 | 19.32 | 18.87 | 13.94 | 19.86 | 29.14 | 25.48 | 22.67 | 29.19 | 37.47 | 47.19 | 55.37 | 63.28 | 0.95 | 6.11 | - | 7.41 | - | 2.6 |
Book Value Per Share | 0.90 | 2.71 | 3.36 | 5.20 | 5.19 | 12.45 | 12.80 | 28.55 | 48.05 | 61.25 | 78.05 | 99.80 | 117.78 | 180.67 | 19.75 | 30.13 | - | -24.49 | - | -1.37 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).